United States

BDR Pharma Applies for CL for Anti-Cancer Drug

BDR Pharma Applies for CL for Anti-Cancer Drug

An anti-cancer drug by American drug giant Bristol-Myers Squibb (BMS) is needed to go on sales. It is, therefore, that a compulsory license (CL) for the same has been applied for by a pharma firm based in Mumbai.

An executive from BDR Pharma said on Monday that the application for sales of BMS's Dasatanib at a very low price had been submitted by them.

TCS settles U.S. class-action suit by agreeing to pay Rs 1580cr

TCS settles U.S. class-action suit by agreeing to pay Rs 1580cr

Indian software giant Tata Consultancy Services (TCS) has agreed to pay nearly $29.8 million (Rs 158 crore) to settle a seven-year-old class action suit in the U. S. filed by two of its former employees.

The class action suit was filed on February 14, 2006, on behalf of Gopi Vedachalam and Kangana Beri, who had accused the company's U. S. division Tata America International Corp (TAIC) of not fulfilling its the promise to give a gross U. S. salary and regular Indian salary while working in the U. S.

The US will become energy-independent as early as 2018: says Mukesh Ambani

The US will become energy-independent as early as 2018: says Mukesh Ambani

Reliance Industries Ltd (RIL) Chairman Mukesh Ambani has said that the United States would become energy-independent as early as 2018.

In a recent interview, Mr. Ambani said that he believed that the US had found non-conventional energy in shale oil and gas, which would make the country independent of foreign energy imports in the next five to seven years.

Speaking on the topic, the billionaire said, "For many decades we have heard that the US will be independent of the foreign imports of energy. Realistically, it is my judgement this will happen in the next five-seven years."

US FAA allows Boeing to resume 787 test flights

US FAA allows Boeing to resume 787 test flights

The US Federal Aviation Administration (FAA) on Thursday allowed Boeing Co to resume test flights of its grounded 787 Dreamliner planes so that it could monitor batteries in flight.

The FAA announced that it had allowed the plane maker to resume test flights of 787 Dreamliner, under more stringent rules, to collect more data on potentially faulty batteries in flight.

Earlier on Thursday, US National Transportation Safety Board's chief Deborah Hersman stressed that regulators must review the conditions that were used to approve lithium-ion battery technology on 787 Dreamliners.

Apple reports lower-than-expected iPhone sales; stock slips

Apple reports lower-than-expected iPhone sales; stock slips

Cupertino, Calif.-based Apple Inc has reported lower-than-expected iPhone sales for the Christmas quarter, despite a whopping jump of 67 per cent in the Chinese market.

The tech giant announced that it sold 47.8 million iPhones in the three months through December 29. The reported figure is considerably lower than analysts' forecast average of nearly 50 million.

Revenue grew 18 per cent the quarter year-on-year to $54.5 billion, down from analysts forecast average of 54.9 billion, while profits remained flat on the previous year at $13.1 billion.

Security Explorations finds two bugs in latest Java version

Security Explorations finds two bugs in latest Java version

In a disclosure which caps one week of bad security news for users of Java software, it has been revealed by Security Explorations that it has discovered two bugs in the latest Java version which can be combined to circumvent the software's sandbox.

787s won’t get green signal until FAA catches cause of fumes in two planes: LaHood

787s won’t get green signal until FAA catches cause of fumes in two planes: LaHo

The US Federal Aviation Administration (FAA) is reluctant to allow Boeing Co.'s 787 Dreamliner planes to fly again unless it gets a clear idea of what caused charring and the release of fumes from the battery packs of two planes earlier this month.

US Transportation Secretary Ray LaHood, whose agency supervises the FAA, declared yesterday that the grounding order on Dreamliners would not lifted until they were "1,000 percent sure" about the safety of the planes.

Stock in Dr Reddy's Lab jumps after Finasteride tablets’ launch in US

Stock in Dr Reddy's Lab jumps after Finasteride tablets’ launch in US

Stock in Dr Reddy's Laboratories gained as much as 2.7 per cent to Rs 1,886.80 a share on the Bombay Stock Exchange (BSE) on Thursday, after the drug firm announced the launch of its generic Finasteride tablets in the American market.

Dr Reddy's Laboratories announced that it had launched Finasteride tablets, for treating male pattern hair loss, in the strength of 1 mg in the U. S. market on January 2 after regulators approved its abbreviated new drug application
(ANDA) with 180-day of marketing exclusivity.

The “fiscal cliff” deal believe to be narrow in scope

The “fiscal cliff” deal believe to be narrow in scope

U. S. President Barack Obama's approval of the budget bill passed by the House of Representatives on the evening of January 1 put an end to the threat that the world's largest economy would be hit by an huge tax hikes that were previously planned to become effective with the start of 2013.

Experts had been cautioning that the proposed $500 billion in new taxes along with automatic spending cuts worth $100 billion would derail the country's economic recovery and throw it into a new recession.

Infosys shares jump 2.4% after US court dismisses harassment case

Infosys shares jump 2.4% after US court dismisses harassment case

Indian software services provider Infosys enjoyed the highest rise in the market value of its stock in more than two months on Tuesday after a U. S. federal judge dismissed harassment charges filed by one of its employees.

Infosys shares, which were weighed down by the announcement of disappointing earnings results and cut in full-year revenue outlook, jumped 2.4 per cent to close at Rs 2,407 on Tuesday.

The positive news also helped push the Bombay Stock Exchange (BSE) index to 17,885 points, its highest close in the last five months.